This third edition of the Japanese Clinical Practice Guidelines for Urinary stones (2023) has been developed under the leadership of the Japanese Urological Association, the Japanese Society of Endourology and Robotics, and the Japanese Society on Urolithiasis Research. This revision adheres to the Minds Manual for Guideline Development (2017) and incorporates new findings from a nationwide survey conducted in 2015, which highlighted the epidemiological characteristics of urolithiasis in Japan since the previous guidelines were published in 2013. A significant advancement in this edition is the systematic review (SR) methodology applied to formulate recommendations for 12 clinical questions (CQs). Both quantitative and qualitative SRs were performed, leading to recommendations determined through consensus among 21 members of the guideline development group. Additionally, nine algorithms were created to support clinical decision-making based on these findings. Topics not addressed by the CQs, considered as foundational knowledge, are outlined in an "Explanation of Related Matters" section, which includes 26 items. This article provides an overview of these guidelines. This section ensures that practitioners have access to comprehensive information, covering aspects of urolithiasis management beyond the scope of the systematic reviews. This article provides an overview of the guidelines, emphasizing their relevance and importance in improving the management and treatment outcomes for patients with urinary stones. The guidelines are designed to be a practical resource for clinicians, facilitating evidence-based care in the evolving landscape of urolithiasis treatment.
International journal of urology : official journal of the Japanese Urological Association. 2025 Feb 10 [Epub ahead of print]
Katsuhito Miyazawa, Satoshi Yamaguchi, Taro Iguchi, Ippei Chikazawa, Takahiro Yasui, Satoru Takahashi, Shiro Hinotsu, Koichiro Akakura, Shizuka Iida, Noritaka Ishito, Takaaki Inoue, Yasuo Kohjimoto, Shinichi Sakamoto, Yoshikazu Sato, Ryoji Takazawa, Tatsuya Takayama, Masao Tsujihata, Yukio Naya, Shuzo Hamamoto, Motoyuki Masai, Takuro Masaki, Junichi Matsuzaki, Soichi Mugiya
Department of Urology, Kanazawa Medical University, Kahoku-gun, Ishikawa, Japan., The Urinary Stone Medical Center, Kitasaito Hospital, Asahikawa, Hokkaido, Japan., Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan., Department of Urology, Nihon University School of Medicine, Itabashi, Tokyo, Japan., Biostatistics and Data Management, Sapporo Medical University, Sapporo, Hokkaido, Japan., JCHO Mishima General Hospital, Mishima, Shizuoka, Japan., Division of Urology, Iida Clinic, Omuta City, Fukuoka, Japan., The Stone Center, Kurashiki Medical Center, Kurashiki, Okayama, Japan., Hara Genitourinary Hospital, Kobe, Hyogo, Japan., Department of Urology, Wakayama Medical University, Wakayama, Wakayama, Japan., Department of Urology, Chiba University Graduate School of Medicine, Chiba, Chiba, Japan., Department of Urology, Sanjukai Urological Hospital, Sapporo, Hokkaido, Japan., Tokyo Metropolitan Otsuka Hospital, Toshima-ku, Tokyo, Japan., Department of Urology, International University of Health and Welfare Hospital, Nasushiobara, Tochigi, Japan., Department of Urology, Osaka Rosai Hospital, Sakai, Osaka, Japan., Department of Urology, Teikyo University Chiba Medical Center, Ichihara, Chiba, Japan., Mihama Hospital, Seijinkai Medical Corporation, Chiba, Chiba, Japan., Department of Urology, Harasanshin Hospital, Fukuoka, Fukuoka, Japan., Department of Urology, Ohguchi Higashi General Hospital, Yokohama, Kanagawa, Japan., Hamamatsu Toyooka Hospital, Hamamatsu, Shizuoka, Japan.